| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 55,359 | 562 | | Cost of Revenue | 51,227 | 405 | | | Gross Profit | 4,132 | 158 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 1,251 | 174 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 2,881 | (16) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,342 |
-
| | Earnings Before Interest And Taxes | 4,223 | (16) | | Interest Expense | 164 |
-
| | Income Before Tax | 4,059 | (16) | | Income Tax Expense | 788 |
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 3,271 | (16) | | | Non-recurring Events | | Discontinued Operations | 62 |
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 3,333 | (16) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $3,333 | ($16) |
|
0.67% Nasdaq 
Income Statement
